Nuclear Medicine and Molecular Imaging

The Korean Society of Nuclear Medicine (대한핵의학회)
권호 표지

A Case of Esophageal Leiomyoma Showing High FDG Uptake on F-18 FDG PET

F-18 FDG PET에서 높은 포도당 섭취를 보인 식도 평활근종 예

  • Lee, Jai-Hyuen (Department of Nuclear Medicine, Dankook University College of Medicine) ;
  • Ryu, Jin-Sook (Department of Nuclear Medicine, Asan Medical Center, University of Ulsan College of Medicine)
  • 이재현 (단국대학교 의과대학 핵의학교실) ;
  • 류진숙 (울산의대 서울아산병원 핵의학과)
  • Published : 2008.08.31
Download PDF
⟨ Previous Next ⟩

Abstract

An esophageal leiomyoma is the most common benign tumor of the esophagus mainly occurred in intramural portion. Occasionaly, it is difficult to discriminate esophageal malignancy from large leiomyoma. Although F-18 FDG PET has been used for differentiating malignant from benign disease, false-positive cases have been reported. Recently, uterine leiomyoma has been reported to have relatively high F-18 FDG uptake in some patients but little is known about how an esophageal leiomyoma might be showed on F-18 FDG PET. We report a case of esophageal leiomyoma that showed high FDG uptake on PET images.

Keywords

References

  1. Arnorsson T, Aberg C, Aberg T. Benign tumours of the oesophagus and oesophageal cysts. Scand J Thorac Cardiovasc Surg 1984;18:145-50 https://doi.org/10.3109/14017438409102396
  2. Lee LS, Singhal S, Brinster CJ, Marshall B, Kochman ML, Kaiser LR, et al. Current management of esophageal leiomyoma. J Am Coll Surg 2004;198:136-46 https://doi.org/10.1016/j.jamcollsurg.2003.08.015
  3. Seremetis MG, Lyons WS, deGuzman VC, Peabody JW, Jr. Leiomyomata of the esophagus. An analysis of 838 cases. Cancer 1976;38:2166-77 https://doi.org/10.1002/1097-0142(197611)38:5<2166::AID-CNCR2820380547>3.0.CO;2-B
  4. Zhu X, Zhang XQ, Li BM, Xu P, Zhang KH, Chen J. Esophageal mesenchymal tumors: endoscopy, pathology and immunohistochemistry. World J Gastroenterol 2007 ;13:768-73 https://doi.org/10.3748/wjg.v13.i5.768
  5. Meirelles GS, Ravizzini G, Yeung HW, Akhurst T. Esophageal leiomyoma: a rare cause of false-positive FDG scans. Clin Nucl Med 2006;31:342-4 https://doi.org/10.1097/01.rlu.0000218771.35887.7a
  6. Blum MG, Bilimoria KY, Wayne JD, de Hoyos AL, Talamonti MS, Adley B. Surgical considerations for the management and resection of esophageal gastrointestinal stromal tumors. Ann Thorac Surg 2007;84:1717-23 https://doi.org/10.1016/j.athoracsur.2007.05.071
  7. Mansour KA, Hatcher CR, Haun CL. Benign tumors of the esophagus: experience with 20 cases. South Med J 1977;70: 461-4 https://doi.org/10.1097/00007611-197704000-00030
  8. Jutley RS, Gray RD, MacKenzie JM, Cockburn JS. A leiomyosarcoma of the oesophagus presenting incidentally without dysphagia. Eur J Cardiothorac Surg 2002;21:127-9 https://doi.org/10.1016/S1010-7940(01)01072-7
  9. Ak I, Ozalp S, Yalcin OT, Zor E, Vardareli E. Uptake of 2-[18F]fluoro-2-deoxy-D-glucose in uterine leiomyoma: imaging of four patients by coincidence positron emission tomography. Nucl Med Commun 2004;25:941-5 https://doi.org/10.1097/00006231-200409000-00012
  10. Chura JC, Truskinovsky AM, Judson PL, Johnson L, Geller MA, Downs LS, Jr. Positron emission tomography and leiomyomas: clinicopathologic analysis of 3 cases of PET scan-positive leiomyomas and literature review. Gynecol Oncol 2007;104:247- 52 https://doi.org/10.1016/j.ygyno.2006.09.024
  11. Kao CH. FDG uptake in a huge uterine myoma. Clin Nucl Med 2003;28:249 https://doi.org/10.1097/00003072-200303000-00025
  12. Lee WL, Yuan CC, Wang PH. Positron emission tomography and uterine leiomyomas. Gynecol Oncol 2007;107:593-4; author reply 4-5 https://doi.org/10.1016/j.ygyno.2007.08.005
  13. Shida M, Murakami M, Tsukada H, Ishiguro Y, Kikuchi K, Yamashita E, et al. F-18 fluorodeoxyglucose uptake in leiomyomatous uterus. Int J Gynecol Cancer 2007;17:285-90 https://doi.org/10.1111/j.1525-1438.2006.00778.x
  14. Dou Q, Zhao Y, Tarnuzzer RW, Rong H, Williams RS, Schultz GS, et al. Suppression of transforming growth factor-beta (TGF beta) and TGF beta receptor messenger ribonucleic acid and protein expression in leiomyomata in women receiving gonadotropin- releasing hormone agonist therapy. J Clin Endocrinol Metab 1996;81:3222-30 https://doi.org/10.1210/jc.81.9.3222
  15. Jeffry L, Kerrou K, Camatte S, Metzger U, Lelievre L, Talbot JN, et al. Endometriosis with FDG uptake on PET. Eur J Obstet Gynecol Reprod Biol 2004;117:236-9 https://doi.org/10.1016/j.ejogrb.2004.04.034
  16. Muck BR, Hommel G. The glycogen content of blood and uterine tissue in women with myoma and endometriosis (author's transl). Arch Gynakol 1976;221:129-37 https://doi.org/10.1007/BF00667142
  17. Tsujikawa T, Yoshida Y, Mori T, Kurokawa T, Fujibayashi Y, Kotsuji F, et al. Uterine Tumors: Pathophysiologic Imaging with 16{alpha}-[18F]fluoro-17{beta}-estradiol and 18F Fluorodeoxyglucose PET-Initial Experience. Radiology 2008;248:599-605 https://doi.org/10.1148/radiol.2482071379